A citation-based method for searching scientific literature


List of co-cited articles
429 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
Tim Heise, Grégory Meiffren, Bertrand Alluis, Cyril Seroussi, Aymeric Ranson, Jorge Arrubla, José Correia, Martin Gaudier, Olivier Soula, Rémi Soula,[...]. Diabetes Obes Metab 2019
22
50

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
Julio Rosenstock, Harpreet S Bajaj, Andrej Janež, Robert Silver, Kamilla Begtrup, Melissa V Hansen, Ting Jia, Ronald Goldenberg. N Engl J Med 2020
53
35

A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5).
David C Klonoff, Mark L Evans, Wendy Lane, Hans-Peter Kempe, Eric Renard, J Hans DeVries, Tina Graungaard, Agon Hyseni, Theis Gondolf, Tadej Battelino. Diabetes Obes Metab 2019
34
29

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1).
David Russell-Jones, Bruce W Bode, Christophe De Block, Edward Franek, Simon R Heller, Chantal Mathieu, Athena Philis-Tsimikas, Ludger Rose, Vincent C Woo, Anne Birk Østerskov,[...]. Diabetes Care 2017
94
29

Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide.
Jonas Kildegaard, Stephen T Buckley, Rasmus H Nielsen, Gro K Povlsen, Torben Seested, Ulla Ribel, Helle B Olsen, Svend Ludvigsen, Claus B Jeppesen, Hanne H F Refsgaard,[...]. Pharm Res 2019
39
25

Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial.
Chantal Mathieu, Bruce W Bode, Edward Franek, Athena Philis-Tsimikas, Ludger Rose, Tina Graungaard, Anne Birk Østerskov, David Russell-Jones. Diabetes Obes Metab 2018
47
25



Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.
Tim Heise, Helle Linnebjerg, David Coutant, Elizabeth LaBell, Eric Zijlstra, Christoph Kapitza, Juliana Bue-Valleskey, Qianyi Zhang, Mary Anne Dellva, Jennifer Leohr. Diabetes Obes Metab 2020
26
30

Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study.
Leslie Klaff, Dachuang Cao, Mary Anne Dellva, Janet Tobian, Junnosuke Miura, Dominik Dahl, Jean Lucas, Juliana Bue-Valleskey. Diabetes Obes Metab 2020
33
25

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
980
22

PEGylated insulin Lispro, (LY2605541)--a new basal insulin analogue.
T M Caparrotta, M Evans. Diabetes Obes Metab 2014
37
22

Insulin analogues in type 1 diabetes mellitus: getting better all the time.
Chantal Mathieu, Pieter Gillard, Katrien Benhalima. Nat Rev Endocrinol 2017
97
19



Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.
Ib Jonassen, Svend Havelund, Thomas Hoeg-Jensen, Dorte Bjerre Steensgaard, Per-Olof Wahlund, Ulla Ribel. Pharm Res 2012
285
19

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial.
Helle Linnebjerg, Qianyi Zhang, Elizabeth LaBell, Mary Anne Dellva, David E Coutant, Ulrike Hövelmann, Leona Plum-Mörschel, Theresa Herbrand, Jennifer Leohr. Clin Pharmacokinet 2020
25
24

A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
54
19

Immunoassay of endogenous plasma insulin in man.
R S YALOW, S A BERSON. J Clin Invest 1960
19

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial.
Keith Bowering, Christopher Case, John Harvey, Michael Reeves, Michael Sampson, Robert Strzinek, Ditte-Marie Bretler, Rikke Beck Bang, Bruce W Bode. Diabetes Care 2017
54
16

Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes.
Eric Zijlstra, Marek Demissie, Tina Graungaard, Tim Heise, Leszek Nosek, Bruce Bode. J Diabetes Sci Technol 2018
27
18

Insulin analogues and their potential in the management of diabetes mellitus.
G B Bolli, R D Di Marchi, G D Park, S Pramming, V A Koivisto. Diabetologia 1999
257
16

Use of fast-acting insulin aspart in insulin pump therapy in clinical practice.
Mark Evans, Antonio Ceriello, Thomas Danne, Christophe De Block, J Hans DeVries, Marcus Lind, Chantal Mathieu, Kirsten Nørgaard, Eric Renard, Emma G Wilmot. Diabetes Obes Metab 2019
21
23


Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetes.
Grit Andersen, Grégory Meiffren, Daniela Lamers, J Hans DeVries, Aymeric Ranson, Cyril Seroussi, Bertrand Alluis, Martin Gaudier, Olivier Soula, Tim Heise. Diabetes Obes Metab 2018
25
20

Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial.
John B Buse, Anders L Carlson, Mitsuhisa Komatsu, Ofri Mosenzon, Ludger Rose, Bo Liang, Kristine Buchholtz, Hiroshi Horio, Takashi Kadowaki. Diabetes Obes Metab 2018
29
17


An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients.
Joseph L Mann, Caitlin L Maikawa, Anton A A Smith, Abigail K Grosskopf, Sam W Baker, Gillie A Roth, Catherine M Meis, Emily C Gale, Celine S Liong, Santiago Correa,[...]. Sci Transl Med 2020
18
27

LAPS Insulin115: A novel ultra-long-acting basal insulin with a unique action profile.
Nina Wronkowitz, Thorsten Hartmann, Sven Wolfgang Görgens, Daniela Dietze-Schroeder, Ira Indrakusuma, In Young Choi, Sung Hee Park, Young-Mi Lee, Se Chang Kwon, Yeonjoo Kang,[...]. Diabetes Obes Metab 2017
19
26

How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes.
Araceli Muñoz-Garach, María Molina-Vega, Francisco J Tinahones. Diabetes Ther 2017
18
27

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial.
Inge B Halberg, Karsten Lyby, Karsten Wassermann, Tim Heise, Eric Zijlstra, Leona Plum-Mörschel. Lancet Diabetes Endocrinol 2019
72
16

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.
Tim Heise, Leszek Nosek, Birgitte Biilmann Rønn, Lars Endahl, Lutz Heinemann, Christoph Kapitza, Eberhard Draeger. Diabetes 2004
415
16

Insulin Access and Affordability Working Group: Conclusions and Recommendations.
William T Cefalu, Daniel E Dawes, Gina Gavlak, Dana Goldman, William H Herman, Karen Van Nuys, Alvin C Powers, Simeon I Taylor, Alan L Yatvin. Diabetes Care 2018
131
16


Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes.
Francesca Porcellati, Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Gianluca Curti, Geremia B Bolli, Carmine G Fanelli. Diabetes Care 2019
22
22

Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.
Mark Warren, Bruce Bode, Jang I Cho, Rong Liu, Janet Tobian, Thomas Hardy, Farai Chigutsa, Moshe Phillip, Barry Horowitz, Debra Ignaut. Diabetes Obes Metab 2021
13
38


New closed-loop insulin systems.
Charlotte K Boughton, Roman Hovorka. Diabetologia 2021
39
16

Review: Glucose-sensitive insulin.
Thomas Hoeg-Jensen. Mol Metab 2021
16
31

'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues.
Mark A Jarosinski, Balamurugan Dhayalan, Nischay Rege, Deepak Chatterjee, Michael A Weiss. Diabetologia 2021
22
22

Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans.
Thomas B Kjeldsen, František Hubálek, Claudia U Hjørringgaard, Tina M Tagmose, Erica Nishimura, Carsten E Stidsen, Trine Porsgaard, Christian Fledelius, Hanne H F Refsgaard, Sanne Gram-Nielsen,[...]. J Med Chem 2021
14
35

Engineering Glucose Responsiveness Into Insulin.
Niels C Kaarsholm, Songnian Lin, Lin Yan, Theresa Kelly, Margaret van Heek, James Mu, Margaret Wu, Ge Dai, Yan Cui, Yonghua Zhu,[...]. Diabetes 2018
42
16


Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18-week, open-label, phase 3 trial (onset 3).
Helena W Rodbard, Devjit Tripathy, Maricela Vidrio Velázquez, Marek Demissie, Søren C Tamer, Milivoj Piletič. Diabetes Obes Metab 2017
31
12

Optimal prandial timing of bolus insulin in diabetes management: a review.
D Slattery, S A Amiel, P Choudhary. Diabet Med 2018
38
12

A review of a family of ultra-rapid-acting insulins: formulation development.
Alan Krasner, Roderike Pohl, Patrick Simms, Philip Pichotta, Robert Hauser, Errol De Souza. J Diabetes Sci Technol 2012
27
14

Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
Klemen Dovc, Claudia Piona, Gül Yeşiltepe Mutlu, Natasa Bratina, Barbara Jenko Bizjan, Dusanka Lepej, Revital Nimri, Eran Atlas, Ido Muller, Olga Kordonouri,[...]. Diabetes Care 2020
38
12

Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.
Bruce W Bode, Violeta Iotova, Margarita Kovarenko, Lori M Laffel, Paturi V Rao, Srikanth Deenadayalan, Magnus Ekelund, Steffen Falgreen Larsen, Thomas Danne. Diabetes Care 2019
18
22



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.